Antenatal magnesium sulphate for protection of the preterm brain in women at risk preterm delivery at 28-36 weeks gestatio
Not Applicable
Recruiting
- Conditions
- Nervous System Diseases
- Registration Number
- PACTR202404671084461
- Lead Sponsor
- Dr Linda James Audu
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 90
Inclusion Criteria
Pregnant women at risk of preterm delivery between 28 to 36weeks of gestation
Preterm prelabour rupture of membranes
Preterm labour
Planned preterm birth for maternal or fetal indication
Exclusion Criteria
Congenital anomaly in the foetus
Second stage of labour
Maternal hypotension
Women who received MgSO4 within the last 12 hrs
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Perinatal death and intraventricular haemorrhage in the preterm newborns
- Secondary Outcome Measures
Name Time Method Apgar scores at birth, type of resuscitation at birth, need for admission of the newborn, hypoxic ischaemic encephalopathy, anaemia requiring blood transfusion will serve as secondary outcomes